Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

Similar documents
Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Approach to the Patient with Liver Disease

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Noninvasive Diagnosis and Staging of Liver Disease. Naveen Gara, MD

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

A Rational Evidence-based Approach to Abnormal Liver Tests

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

Non-Invasive Assessment of Liver Fibrosis. Patricia Slev, PhD University of Utah Department of Pathology

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University

Disclosure. Evaluation of Abnormal Hepatic Enzymes

Pretreatment Evaluation

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

What are LFTs? What are LFTs? 3/20/2017. Evaluation of Abnormal Liver Chemistry Tests. Transaminases. Alkaline phosphatase.

Non-Invasive Testing for Liver Fibrosis

Faculty Disclosure. Objectives. Cirrhosis Management for the Family Physician 18/11/2014

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon

Hepatology for the Nonhepatologist

Interpreting Liver Tests What Do They Mean? Roman E. Perri, MD

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS

Pretreatment Evaluation

Break the Liver Biopsy Habit

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

When to Treat: Staging Liver Disease David L. Thomas, MD, MPH

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER

Investigating and Referring Incidental Findings of Abnormal Liver Tests

EVALUATION OF ABNORMAL LIVER TESTS

Morning Report Presentation. Sarah Hughes, MD January 11, 2005

-Liver function tests -

Monitoring Hepatitis C

Module 1 Introduction of hepatitis

Hepatology For The Nonhepatologist

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS

CrackCast Episode 28 Jaundice

Laboratory evaluation of the patient with liver disease

Interpreting Your Tests

9/28/2016. Elevated Liver Function Tests: A Case Based Approach. Objectives. Identify patterns of abnormal liver function tests

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

Liver Cases for the Primary Care Provider

Harvard Medical School

Liver failure &portal hypertension

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

Update on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic

Approach to Abnormal Liver Tests

Dhanpat Jain Yale University School of Medicine, New Haven, CT

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

Radiology Update 2017

Biochemistry Liver Function Tests (LFTs)

Liver care in HIV Abnormal LFT s management

AASLD Immune tolerant phase HBV NAFLD diagnostic HCC

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

Joslin Diabetes Center Advances in Diabetes and Thyroid Disease 2013 Nonalcoholic Fatty Liver Disease: The Burgeoning Epidemic

Liver imaging the revolution

Managing abnormal LFTs in Primary care

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark

NONINVASIVE TECHNIQUES FOR EVALUATION AND MONITORING OF CHRONIC LIVER DISEASE

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Approach to the Patient with Abnormal Liver Enzymes

ACCME/Disclosures. The Overlap Syndromes: Do They Exist? Key Points and Questions 4/6/2016. Hans Popper Hepatopathology Society

Biliary Stones. Biliary Stones. Biliary Stones. Chapter XI K00-K93 Digestive System. ำ จ ยทางค ก (Clinical Diagnosis)

Pretreatment Evaluation

In Search of New Biomarkers for Nonalcoholic Fatty Liver Disease

HEPATOLOGY COPYRIGHTED MATERIAL

Gastrointes*nal and Liver Pathology. Kris*ne Kra5s, M.D.

Extrahepatic Biliary Obstruction. Ductal Diseases: Stones Tumors. Acute Injury: Viral Hepatitis Toxin (APAP/Etoh) Reye s Shock.

1. Based on A.S. s labs and presentation, what type of liver injury would you classify her as experiencing?

ABNORMAL LIVER TESTS

Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis

Index. Note: Page numbers of article titles are in boldface type.

Management of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France

Liver 102: Injury and Healing

Primary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants

COPYRIGHT. Gastroenterology and Hepatology: Challenging Cases. Sanjiv Chopra, MD, MACP. Professor of Medicine

Transient elastography in chronic liver diseases of other etiologies

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT

May 2015 CLINICAL REFERENCE. gastroenterology

Key Points: Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective. Jenny Heathcote, MD. University of Toronto

NON INVASIVE EVALUATION OF DISEASE PROGRESSION IN CHRONIC LIVER DISEASES

LIVER DISEASES. Anatomy

LFTs: an update A MacGilchrist PLIG meeting 31st January 2019

NAFLD and NASH: The Not-So-New Kids on the Block

Imaging of liver and pancreas

Learning Objectives. Case 1. Case Presentations. Interpretation of Liver Tests. Interpretation of Liver Tests. Presenter Disclosure Information

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

27 th Reviews in Internal Medicine for 3 rd Year Medicine Resident Approach to Common Problems in. Gastroenterology

The Rise And Fall of Liver Biopsy

Interpreting Liver Function Tests

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014

Dr. R. Pradheep. DNB Resident Pediatrics. Southern. Railway. Hospital.

Alice Fung, MD Oregon Health and Science University

Drug therapy in patient with hepatic impairment

Transcription:

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland Sanjiv Chopra, MD, MACP Professor of Medicine Harvard Medical School Editor In Chief Hepatology Section Up To Date

Serum Aminotransferases Levels Exceeding 500 IU/L Acute viral hepatitis Drug or toxic liver injury Ischemic hepatitis Severe C.A.H. CBD stone Budd Chiari and V.O.D. Acute Fatty Liver of Pregnancy and HELLP Wilson s disease

Serum Aminotransferases AST : ALT greater than 2 Both less than 300 IU/L Characteristic of alcoholic liver disease

Serum Aminotransferases AST and ALT elevated Comprehensive blood work-up unrevealing Liver biopsy normal Muscle Source Suspect!

Celiac Sprue Can Cause Chronic Unexplained ALT Elevations 140 consecutive patients with a comprehensive negative serologic work-up studied. 13 patients (9.3%) had positive antigliadin and antiendomysial antibody tests. Duodenal biopsies consistent with sprue. Liver biopsies revealed non-specific changes. ALT and AST usually normalize on a gluten free diet. Bardella MT, et al. Hepatology 1999: 29, 654

Four Causes of Unexplained ALT (SGPT) Elevations 1. Muscle Disease/Injury (CPK) 2. Celiac Sprue (TTG antibody) 3. Adrenal Insufficiency (Cortisol) 4. Thyroid Dysfunction (TSH) MCAT

Very Low ALT Levels A 57 year old male has a serum ALT of 4 IU/L. It is repeated and found to be 1 IU/L. Choose the correct answer(s). He likely has: A) Chronic Renal Failure B) Pyridoxine Deficiency C) B12 Deficiency Correct answer is A and B

We need to Think Differently about the Upper Normal Limit of ALT True normal healthy ALT: 19 to 25 IU/L in females 29 to 33 IU/L in males Multiple studies: Elevated ALT associated with increased liver-related mortality. Likely, many of the newly identified patients using these parameters will have NAFLD.

Serum Alkaline Phosphatase Sources 1. Liver 2. Bone 3. Small intestine 4. Placenta 5. Other, e.g., Regan isoenzyme

Serum Alkaline Phosphatase Patients with cholestasis have increased levels Level not helpful in distinguishing intrahepatic from extrahepatic cholestasis Rarely patients with hypernephroma and Hodgkin s have elevated levels in absence of liver involvement Patients with Wilson s disease often have normal or below normal values

Rare cause of elevated Alkaline Phosphatase Cholestasis may be seen rarely in patients with hypernephroma as part of a paraneoplastic syndrome. This is referred to as nephrogenic hepatic dysfunction syndrome or Stauffer s syndrome. The cause is unknown but may relate to secretion of IL-6.

When Is Jaundice An Emergency? 1. Severe unconjugated hyperbilirubinemia in the newborn. 2. When patient has fulminant hepatic failure. 3. When patient has cholangitis. 4. When patient has massive hemolysis.

Alcoholic Hepatitis Discriminant Function Value Prothrombin time - Control x 4.6 plus Serum bilirubin (in mg/dl) Value > 32, mortality 50%!

Causes of low serum Albumin 1. Malnutrition 2. Liver disease 3. Nephrotic syndrome 4. Protein losing enteropathy

Serum Globulins 1. Increased IgG A. A young woman with abnormal LFT s and arthralgias 2. Increased IgA B. A 42 year old salesman with hepatomegaly, spider nevi and AST of 112 IU/L 3. Increased IgM C. A 57 year old white woman with hypothyroidism and pruritis

Increased Serum Globulins Answers 1. Increased IgG Autoimmune Hepatitis 2. Increased IgA Alcoholic Liver Disease 3. Increased IgM Primary Biliary Cirrhosis

Serum Ferritin Elevated 1. Idiopathic genetic hemochromatosis 2. Hepatocellular necrosis 3. Hodgkin s 4. Leukemia 5. Hyperthyroidism 6. Uremia 7. Rheumatoid arthritis

Liver Ultrasound Hepatic lesions Ascites Gallstones Jaundice

Gallstones: Ultrasound

Computed Tomography Hepatic lesions Jaundice Budd-Chiari syndrome Iron overload

Utility of CT: Liver Abscess

Utility of CT: Liver Abscess

The Roles of Imaging Detect Diagnose Stage Plan treatment Treat

Contemporary CT scanning helps plan surgical approach

CT: Virtual hepatectomy

Ominous imaging features Tumor thrombus Caval extension

Magnetic Resonance Imaging (MRI) Hepatic metastases Vascular lesions, e.g., hemangioma Hepatic and portal vein Iron overload

MRI: Hepatic Hemangioma

MRI: Clarity of Vascular Structures

Stigmata of Chronic Liver Disease

Stigmata of Chronic Liver Disease

A Medical Limerick! An older Miss Muffett Decided to rough it And lived upon Whiskey and Gin Red hands and a spider Developed outside her Such are the wages of sin Dr. Bean

34 year old woman DATE Serum Alk Phos 1/13/99 19 (normal 40-118 IU/L) 2/24/00 18 4/13/00 168 6/29/00 262 2/1/01 16 Each lab value is WHAT S THE DIAGNOSIS?

Eye Findings in Wilson s Disease K-F Ring

Sunflower Cataract in Wilson s Disease

Is Liver Biopsy the Gold Standard? Liver biopsy has been considered to be the Gold Test. However, it is invasive, subject to sampling and on rare occasions there can be serious complications. Is there a non-invasive alternative to evaluating the degree of hepatic fibrosis?

Sampling error of liver biopsy Fibrosis area: 65% Fibrosis area: 15% Courtesy of M. Pinzani, Florence

Fibrotest (fibrosure) Alpha 2 macroglobulin, haptoglobin, gammaglobulin, GGT, total bilirubin, apolipoprotein A1 The severity of disease was correctly identified in 46% of patients. Am J Gastroenterol 2006 Fibrosure. I am not so sure!

Fibroscan Examination time < 5 minutes Median value of 10 successful acquisitions Sampling error Biopsy 1/50,000 Fibroscan 1/500 Courtesy of N. Afdhal, MD

Hepatic Elastography Sampled volume: 1: 500 Courtesy N. Afdhal, MD

Sampling Liver biopsy samples only 1/50,000 th of whole liver. Fibroscan samples 1/500 th of whole liver.

Advantage of Fibroscan Liver transient elastography obviates the need for inaccurate and invasive liver biopsies The actual stiffness score can provide us with an accurate glimpse of staging cirrhosis on a continuum

Emerging Scenario Patients with suspected Liver Disease Biomarkers and Fibroscan Low likelihood of fibrosis Grey zone High likelihood of fibrosis No liver biopsy Follow or treat Liver biopsy No liver biopsy Screen HCC, varices